Low- and middle-income countries
36 articles
HIV and Viral Hepatitis Diagnostic Tests in LMICs: Forecasts of Global and Regional Demand for 2022-2026
WHO releases a report jointly presenting diagnostic test forecasts across disease areas in recognition of the benefits of addressing HIV and viral hepatitis B and C in a coordinated manner. More
From Principle to Practice: Involving Communities in Research Design for Effective Hepatitis C Prevention
Unitaid’s funding to support the integration of hepatitis C testing and treatment in harm reduction services, while trialing the use of two underused products to prevent infection. More
The Cost of Complacency: A Harm Reduction Funding Crisis
Harm Reduction International releases its annual report exploring the state of harm reduction funding in low- and middle-income countries. More
WHO Prequalifies the First Self-Test for Hepatitis C Virus
WHO has prequalified the first HCV self-test which can provide a critical support in expanding access to testing and diagnosis, accelerating global efforts to eliminate hepatitis C. More
Long-Acting Therapies Trials Tracker for Hepatitis C, Opioid Use and Overdose Prevention Therapy, and Malaria
Treatment Action Group releases a trials tracker providing a compilation of ongoing and recently completed clinical trials on long-acting therapies for HCV, malaria, and opioid use and overdose prevention in the R&D pipeline. More
